Department of Genetics faculty, postdocs, students and collaborators published 18 papers during August 8th – 21st, 2021.

The laboratory of Dr. Jason Stein (Assistant Professor, Genetics and Neuroscience Center) published a paper titled “Brain-trait-associated variants impact cell-type specific gene regulation during neurogenesis” in the American Journal of Human Genetics (19 Aug 2021 issue).

Drs. Jason Stein (Assistant Professor) and Hyejung Won (Assistant Professor) have been awarded an U01 grant from the National Institutes of Mental Health (NIMH) for their project titled “Discovery and validation of genetic variation impacting the gene regulatory landscape during human cortical development”.

Department of Genetics faculty, postdocs, students and collaborators published twenty one papers during June 13-26, 2021.

Department of Genetics faculty, postdocs, students and collaborators published nineteen papers during May 16-29, 2021.

Dr. Jason Stein (Assistant Professor, Department of Genetics) and colleagues have published a manuscript in Nature Neuroscience (20 May 2021) titled “Cell-type specific effects of genetic variation on chromatin accessibility during human neuronal differentiation”.

Department of Genetics faculty, postdocs, students and collaborators published thirteen papers during April 18 – May 1, 2021.

The UNC Department of Genetics Research Colloquium welcomes Jason Stein, Assistant Professor, UNC Department of Genetics and the UNC Neuroscience Center on Wednesday, March 17, 2020. This talk title is “Genetic influences on human cortical development and structure”. This seminar will be broadcast via Zoom. Link will be provided through UNC Department of Genetics emails. … Continued

Department of Genetics faculty, postdocs, students and collaborators published ten papers during November 29 – December 12, 2020.

Department of Genetics faculty, postdocs, students and collaborators published 18 papers during October 11-31, 2020.     Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer.  Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, … Continued